Morgan Stanley Roivant Sciences Ltd. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Morgan Stanley holds 35,635,501 shares of ROIV stock, worth $369 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
35,635,501
Previous 21,927,044
62.52%
Holding current value
$369 Million
Previous $246 Million
52.53%
% of portfolio
0.03%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding ROIV
# of Institutions
263Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$757 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$719 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$691 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$375 Million0.01% of portfolio
-
Rubric Capital Management LP New York, NY20MShares$207 Million7.19% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...